"Center for Podiatry Care-Aiyan Diabetes Center"

During the past decade, Aiyan Diabetes Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aiyan Diabetes Center" #1 sponsor was "Xequel Bio, Inc." with 2 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Baxter Healthcare Corporation" with 1 trials sponsored, "Cytomedix" with 1 trials sponsored and "Indiana University" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aiyan Diabetes Center" #1 collaborator was "Medical University of South Carolina" with 2 trials as a collaborator, "Spartanburg Regional Healthcare System" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Aiyan Diabetes Center" with 1 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Aiyan Diabetes Center" are "Diabetic Foot Ulcers" (4 trials), "Diabetic Foot" (2 trials), "Foot Ulcer" (2 trials), "Venous Leg Ulcer" (2 trials) and "Wounds" (2 trials). Many other conditions were trialed in "Aiyan Diabetes Center" in a lesser frequency.

Most popular intervention types in "Aiyan Diabetes Center" are "Device" (5 trials), "Other" (4 trials), "Drug" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AutoloGel System" (1 trials), "Cilostazol" (1 trials), "Control" (1 trials), "Dermagraft(R)" (1 trials) and "Drink mix calorically similar to experimental product" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aiyan Diabetes Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Aiyan Diabetes Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Aiyan Diabetes Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Aiyan Diabetes Center, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".